Zobrazeno 1 - 10 of 697 pro vyhledávání: '"T. Rispens"'
1
Akademický článek
Adherence to preventive measures after SARS-CoV-2 vaccination and after awareness of antibody response in kidney transplant recipients in the Netherlands: a nationwide questionnaire studyResearch in context
Autor: Sophie C. Frölke, Pim Bouwmans, A. Lianne Messchendorp, Johanna P.M. Vervoort, Alferso C. Abrahams, Aiko P.J. de Vries, Pythia T. Nieuwkerk, Marc H. Hemmelder, Ron T. Gansevoort, Luuk B. Hilbrands, Marlies E.J. Reinders, Jan-Stephan F. Sanders, Frederike J. Bemelman, Suzanne E. Geerlings, C. Imhof, C. Idzinga, C. Siegert, C.C. Baan, C.J.A.M. Konings, C. van Kessel, D. van Baarle, D.A. Diavatopoulos, D. Standaar, E. ten Hoope, E. Til, E.B.M. Remmerswaal, F. van der Klis, H.R. Fritsen, I. Stijnman, J.N. Brinkman, J. Cheng, L. den Biggelaar, M. ten Dam, M. Steenhuis, M. Zwerink, M.H.J. Braks, M. Willems, M.L. Kho, N. Rots, P. Vart, R.G. van der Molen, R.M.A. van den Dorpel, R.S.R.K. Malaha, R.C.G. ter Meulen, T. Rispens, T. Steenvoorden, T. de Ronde, V.J.P. Peters, W.S. Konijn, W.M.T. Janssen, W.J. Bos, Y.M.R. Adema, Y. Vegting
Publikováno v: EClinicalMedicine, Vol 62, Iss , Pp 102103- (2023)
Summary: Background: Kidney transplant recipients (KTRs) were advised to tightly adhere to government recommendations to curb the spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) because of a high risk of morbidity and mortality
Externí odkaz: https://doaj.org/article/2b53151bf4f04e7f8da35249bd401c82
Zobrazit plný text záznamu
2
Akademický článek
Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study
Autor: P. Bouwmans, A. L. Messchendorp, J. S. Sanders, L. Hilbrands, M. E. J. Reinders, P. Vart, F. J. Bemelman, A. C. Abrahams, M. A. van den Dorpel, M. A. Ten Dam, A. P. J. de Vries, T. Rispens, M. Steenhuis, R. T. Gansevoort, M. H. Hemmelder, RECOVAC Collaborators
Publikováno v: BMC Nephrology, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background COVID-19 is associated with increased morbidity and mortality in patients with chronic kidney disease (CKD) stages G4-G5, on dialysis or after kidney transplantation (kidney replacement therapy, KRT). SARS-CoV-2 vaccine trials do
Externí odkaz: https://doaj.org/article/db49c9e3f51e4744ab4bb295e6b08127
Zobrazit plný text záznamu
3
Akademický článek
Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)
Autor: A. Nassar-Sheikh Rashid, D. Schonenberg-Meinema, S. C. Bergkamp, S. Bakhlakh, A. de Vries, T. Rispens, T. W. Kuijpers, G. Wolbink, J. M. van den Berg
Publikováno v: Pediatric Rheumatology Online Journal, Vol 19, Iss 1, Pp 1-8 (2021)
Abstract Background Anti-tumor necrosis factor (TNF) drugs have improved the prognosis for juvenile idiopathic arthritis (JIA) significantly. However, evidence for individual treatment decisions based on serum anti-TNF drug levels and the presence of
Externí odkaz: https://doaj.org/article/db897afe19e841259d9f4dfc996936d3
Zobrazit plný text záznamu
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
7
Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a randomized controlled trial
Autor: J Ruwaard, MJ L’ Ami, EL Kneepkens, CLM Krieckaert, MT Nurmohamed, F Hooijberg, AWR van Kuijk, JC van Denderen, L Burgemeister, T Rispens, M Boers, GJ Wolbink
Publikováno v: Scandinavian journal of rheumatology. Informa Healthcare
Ruwaard, J, l’ Ami, M J, Kneepkens, E L, Krieckaert, C L M, Nurmohamed, M T, Hooijberg, F, van Kuijk, A W R, van Denderen, J C, Burgemeister, L, Rispens, T, Boers, M & Wolbink, G J 2022, ' Interval prolongation of etanercept in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis : a randomized controlled trial ', Scandinavian Journal of Rheumatology . https://doi.org/10.1080/03009742.2022.2028364
Scandinavian Journal of Rheumatology. Informa Healthcare
Objective: The majority of patients with a rheumatic disease treated with etanercept may be overexposed. Data regarding etanercept tapering are scarce, particularly in psoriatic arthritis (PsA) and ankylosing spondylitis (AS). We compared extending t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ef1c12c8fadcb65cb3ab4762f6e5d61
https://doi.org/10.1080/03009742.2022.2028364
Zobrazit plný text záznamu
8
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands
Autor: Laura Y Kummer, Sofie Keijzer, Erik H Vogelzang, Gertjan Wolbink, Laura Boekel, Luuk Wieske, Filip Eftimov, Maurice Steenhuis, Michael T Nurmohamed, Ronald van Vollenhoven, Gestur Vidarsson, T. Rispens, Koos P J van Dam, Joep Killestein, Olvi Cristianawati, S. Marieke van Ham, Zoé L.E. van Kempen, Yaëlle R Besten, Eileen W Stalman, Sander W. Tas, Alexandre E Voskuyl, Taco W. Kuijpers, Femke Hooijberg, Maarten Boers
Publikováno v: Boekel, L, Steenhuis, M, Hooijberg, F, Besten, Y R, van Kempen, Z L E, Kummer, L Y, van Dam, K P J, Stalman, E W, Vogelzang, E H, Cristianawati, O, Keijzer, S, Vidarsson, G, Voskuyl, A E, Wieske, L, Eftimov, F, van Vollenhoven, R, Kuijpers, T W, van Ham, S M, Tas, S W, Killestein, J, Boers, M, Nurmohamed, M T, Rispens, T & Wolbink, G 2021, ' Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands : a substudy of data from two prospective cohort studies ', The Lancet Rheumatology, vol. 3, no. 11, pp. e778-e788 . https://doi.org/10.1016/S2665-9913(21)00222-8, https://doi.org/10.1016/S2665-9913(21)00222-8
The Lancet. Rheumatology, 3(11), e778-e788. Elsevier Ltd
The Lancet. Rheumatology
The Lancet Rheumatology, 3(11), e778-e788. Lancet Publishing Group
Background: Data are scarce on immunogenicity of COVID-19 vaccines in patients with autoimmune diseases, who are often treated with immunosuppressive drugs. We aimed to investigate the effect of different immunosuppressive drugs on antibody developme
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5058ec41cc875d2674bd64b83a76a66b
https://dare.uva.nl/personal/pure/en/publications/antibody-development-after-covid19-vaccination-in-patients-with-autoimmune-diseases-in-the-netherlands(036a10d7-30ae-4847-93fc-d95a956d1c63).html
Zobrazit plný text záznamu
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Presence of SARS-CoV-2 antibodies in patients with COVID-19 like symptoms from the IENIMINI cohort
Autor: L van Ouwerkerk, D van der Woude, T Rispens, CF Allaart, TWJ Huizinga
Publikováno v: Scandinavian journal of rheumatology. Informa Healthcare
Scandinavian Journal of Rheumatology. TAYLOR & FRANCIS LTD
Scandinavian Journal of Rheumatology
Objective: To evaluate the relationship between reported coronavirus disease 2019 (COVID-19)-like symptoms and the presence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibodies in patients with an immune-mediated inflammatory di
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bd984e936ddec17cd66f41ec4ed9e3d
https://pubmed.ncbi.nlm.nih.gov/35833317
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje